RenovoRx appoints Richard Stark to board of directors
RNXT•RenovoRx appointed Richard A. Stark to its board; he has advised the company’s commercial team since late 2024.
1. Board appointment
RenovoRx appointed Richard A. Stark to its board of directors. Stark is CEO of Innoblative Designs and has more than three decades of medical technology leadership experience focused on interventional oncology commercialization.




